Interactions with the cardiac cholinergic system: Effects of disopyramide and its mono-n-dealkylated metabolite
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 50 (20) , PL161-PL166
- https://doi.org/10.1016/0024-3205(92)90148-i
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of Anticholinergic Effects of Cibenzoline, Disopyramide, and AtropineJournal of Cardiovascular Pharmacology, 1990
- Muscarinic receptors mediate negative and positive inotropic effects in mammalian ventricular myocardium: differentiation by agonistsBritish Journal of Pharmacology, 1987
- Comparative Effects of Disopyramide and Its Mono- N-Dealkylated Metabolite in Conscious Dogs with Chronic Atrioventricular BlockJournal of Cardiovascular Pharmacology, 1986
- Class I antiarrhythmic agents: Quinidine, procainamide and N-acetylprocainamide, disopyramidePharmacology & Therapeutics, 1983
- Plasma binding of disopyramide and mono-N-dealkyldisopyramide.British Journal of Clinical Pharmacology, 1982
- Plasma concentrations and protein binding of disopyramide and mono‐N‐ dealkyldisopyramide during chronic oral disopyramide therapy.British Journal of Clinical Pharmacology, 1981
- Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.Circulation Research, 1980
- Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.Circulation, 1979
- Disopyramide: Serum level and arrhythmia conversionAmerican Heart Journal, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973